SCHEMBL6375844

SCHEMBL6375844

CCc1nnc(NC(=O)/C(C#N)=C/c2cc(OC)c(O)c([N+](=O)[O-])c2)s1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.64
▸ MEN1 O00255 2/20 0.60
▸ ALDH1A1 P00352 2/20 0.60
▸ MAPT P10636 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ NPC1 O15118 1/20 0.60
▸ ESRRA P11474 7/20 0.58
▸ CSNK2A1 P68400 7/20 0.56
▸ FTO Q9C0B1 2/20 0.54
▸ CSNK2A2 P19784 1/20 0.51
▸ CSNK2B P67870 1/20 0.51
▸ CSNK2A3 Q8NEV1 1/20 0.51
▸ SRPK1 Q96SB4 1/20 0.51
▸ POLB P06746 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ BLM P54132 1/20 0.50
▸ MCL1 Q07820 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6375848 1.00 EGFR (0.64) EGFRMEN1ALDH1A1MAPTKMT2A
SCHEMBL6379909 0.91 ESRRA (0.65) EGFRMEN1MAPTKMT2AESRRA
SCHEMBL6379899 0.91 ESRRA (0.65) EGFRMEN1MAPTKMT2AESRRA
SCHEMBL6372564 0.89 ESRRA (0.63) EGFRMEN1MAPTKMT2AESRRA
SCHEMBL6372570 0.89 ESRRA (0.63) EGFRMEN1MAPTKMT2AESRRA
SCHEMBL6375942 0.86 ESRRA (0.60) MEN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL6375944 0.86 ESRRA (0.60) MEN1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL6373841 0.85 CSNK2A1 (0.78) MEN1ALDH1A1MAPTKMT2ANPC1
SCHEMBL6373838 0.85 CSNK2A1 (0.78) MEN1ALDH1A1MAPTKMT2ANPC1
SCHEMBL6374555 0.84 ESRRA (0.76) EGFRMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 — — WO claimed
WO-2005072731-A1 3-PHENYL-N- ((1, 3, 4) THIADIAZOL-2-YL) -ACRYLAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ESTROGEN-RELATED RECEPTORS FOR THE TREATMENT OF E.G. CANCER, RHEUMATOID ARTHRITIS OR NEUROLOGICAL DISORDERS X-CEPTOR THERAPEUTICS, INC. (US) 2005-08-11 — — WO disclosed
Send feedback